ABIGAIL EUBANK: Open Payments
NPI 1588861207 · HENDERSONVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$856 in 56 payments from 10 companies in 2025. Trend: 2023 $638 · 2024 $1,027 · 2025 $856
Food & beverage: $856
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $258 |
| Novo Nordisk Inc | 16 | $173 |
| PFIZER INC. | 4 | $85 |
| Lilly USA, LLC | 4 | $84 |
| Sumitomo Pharma America, Inc. | 3 | $71 |
| Corcept Therapeutics | 3 | $61 |
| Novartis Pharmaceuticals Corporation | 3 | $61 |
| Abbott Laboratories | 1 | $28 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| PUMA BIOTECHNOLOGY, INC. | 1 | $14 |
Products named: UBRELVY, Ozempic, VRAYLAR, NURTEC ODT, GEMTESA, Korlym, LEQVIO, MOUNJARO.
Industry payments across TN — which companies pay providers there.
